Tirzepatide vs Mazdutide
Both are dual agonists and both act on the GLP-1 receptor. The difference is the second receptor: tirzepatide adds GIP-receptor activity on a GIP-based backbone, while mazdutide adds glucagon-receptor activity on an oxyntomodulin-based backbone. Both came out of Eli Lilly's incretin research; mazdutide was then developed in China by Innovent Biologics.
Edited by Alex James, Founder and editor
Dual GIP and GLP-1 receptor agonist
Choose Tirzepatide if
- ✓ You need an approved, widely characterised dual-agonist reference
- ✓ Your question is about GIP-receptor signalling alongside GLP-1
GLP-1 and glucagon receptor dual agonist, approved in China
Choose Mazdutide if
- ✓ Your question is about glucagon-receptor activity alongside GLP-1
- ✓ You are studying oxyntomodulin analogues
Side-by-side specification
| Compare | Tirzepatide Dual GIP and GLP-1 receptor agonist | Mazdutide GLP-1 and glucagon receptor dual agonist, approved in China |
|---|---|---|
| Class | Dual GIP / GLP-1 receptor agonist | Dual GLP-1 / glucagon receptor agonist (oxyntomodulin analogue) |
| Research area | Metabolic | Metabolic |
| Receptor targets | GIPR, GLP-1R | GLP-1R, GCGR |
| Length | 39 amino acids (acylated) | Modified oxyntomodulin-based peptide (fatty-acid conjugated) |
| Molecular mass | ≈ 4.81 kDa | Not fully published (large acylated peptide, several kDa) |
| Origin | Synthetic, GIP-based sequence | Synthetic, oxyntomodulin-based sequence |
| Evidence level | 5/5 Approved drug, phase 3 trials | 4/5 Late-stage human trials |
| Regulatory status | Approved prescription medicine | Approved in China |
| Nordapep from | — | — |
| Best price per mg | — | — |
| Browse Nordapep → | Browse Nordapep → |
What separates them
Tirzepatide is approved by the MHRA, EMA and FDA and rated 5. Mazdutide was approved in China in 2025 but nowhere else, and is rated 4, with human data mostly from Chinese study populations. We are not aware of a published head-to-head trial between the two.
Read the full guides for Tirzepatide and Mazdutide, or add a third compound in the comparison tool.
FAQ
Do tirzepatide and mazdutide hit the same receptors?
They share one. Both activate the GLP-1 receptor; tirzepatide also activates the GIP receptor, and mazdutide also activates the glucagon receptor.
Is mazdutide approved outside China?
No. As of November 2026 it is approved by China's NMPA only. Tirzepatide is approved in the UK, EU and US. Research-grade material of either is for in vitro laboratory work only.
Are Tirzepatide and Mazdutide approved medicines?
Tirzepatide: Approved prescription medicine. Mazdutide: Approved in China. Research-grade material of either is not a medicine and is supplied for in vitro research only.
Where can I buy Tirzepatide and Mazdutide?
Nordapep lists compounds with a Certificate of Analysis matched to the batch reference. Check each compound page for current availability.
More comparisons
Where to buy
Why we send researchers to Nordapep
Comparing compounds is only half the job. The other half is knowing the vial contains what the label says. Nordapep publishes batch documentation for every compound it sells.
Browse the Nordapep catalogue →Each batch reference on the label matches its CoA, so you can check what is in the vial.
Enter the batch reference from your vial into Nordapep's batch-verification tool.
Purity is reported by RP-HPLC, the standard method for peptides of this size.
Bundled stacks for common comparisons, plus tiered pricing for volume orders.